MYD88 and Alzheimer disease: Considering the data evidencing increased levels of MYD88 in the AD brain, it is possible that neuronal damage in AD and the consequent release of DAMPs could have an echo in the periphery and prime blood leukocytes [28] by increasing the transcription of MYD88, as reported in the present study.